CCL5 and pancreatic neoplasm: Conversely, CCL5 expression levels in the stroma were decreased in orthotopic pancreatic tumors of neutrophil-depleted mice (Fig. 1J), confirming TANs as a major source of CCL5 in the PDAC TME.